Recent advances and developments in COVID-19 in the context of allergic diseases

Basit Öğe Kaydı
dc.authoridvan de Veen, Willem/0000-0001-9951-6688
dc.authoridAkdis, Cezmi/0000-0001-8020-019X
dc.authoridAkdis, Mubeccel/0000-0003-0554-9943
dc.authoridDong, Xiang/0000-0002-5241-4307
dc.authoridYadong, GAO/0000-0003-1251-7608
dc.authoridAZKUR, DILEK/0000-0002-4396-9087
dc.authoridSokolowska, Milena/0000-0001-9710-6685
dc.contributor.authorDing, Mei
dc.contributor.authorDong, Xiang
dc.contributor.authorSun, Yuan-li
dc.contributor.authorSokolowska, Milena
dc.contributor.authorAkdis, Mubeccel
dc.contributor.authorvan de Veen, Willem
dc.contributor.authorAzkur, Ahmet Kursat
dc.date.accessioned2025-01-21T16:43:56Z
dc.date.available2025-01-21T16:43:56Z
dc.date.issued2021
dc.departmentKırıkkale Üniversitesi
dc.description.abstractBackground Since the first reports of coronavirus disease 2019 (COVID-19) in Wuhan, China, in December 2019, there have been 198 million confirmed cases worldwide as of August 2021. The scientific community has joined efforts to gain knowledge of the newly emerged virus named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the immunopathological mechanisms leading to COVID-19, and its significance for patients with allergies and asthma. Methods Based on the current literature, recent advances and developments in COVID-19 in the context of allergic diseases were reviewed. Results and Conclusions In this review, we discuss the prevalence of COVID-19 in subjects with asthma, attacks of hereditary angioedema, and other allergic diseases during COVID-19. Underlying mechanisms suggest a protective role of allergy in COVID-19, involving eosinophilia, SARS-CoV-2 receptors expression, interferon responses, and other immunological events, but further studies are needed to fully understand those associations. There has been significant progress in disease evaluation and management of COVID-19, and allergy care should continue during the COVID-19 pandemic. The European Academy of Allergy & Clinical Immunology (EAACI) launched a series of statements and position papers providing recommendations on the organization of the allergy clinic, handling of allergen immunotherapy, asthma, drug hypersensitivity, allergic rhinitis, and other allergic diseases. Treatment of allergies using biologics during the COVID-19 pandemic has also been discussed. Allergic reactions to the COVID-19 vaccines, including severe anaphylaxis, have been reported. Vaccination is a prophylactic strategy that can lead to a significant reduction in the mortality and morbidity associated with SARS-CoV-2 infection, and in this review, we discuss the proposed culprit components causing rare adverse reactions and recommendations to mitigate the risk of anaphylactic events during the administration of the vaccines.
dc.identifier.doi10.1002/clt2.12065
dc.identifier.issn2045-7022
dc.identifier.issue7
dc.identifier.pmid34582102
dc.identifier.scopus2-s2.0-85115865815
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1002/clt2.12065
dc.identifier.urihttps://hdl.handle.net/20.500.12587/25364
dc.identifier.volume11
dc.identifier.wosWOS:000700512800005
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofClinical and Translational Allergy
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241229
dc.subjectallergy; COVID-19; mechanism; treatment; vaccination
dc.titleRecent advances and developments in COVID-19 in the context of allergic diseases
dc.typeReview Article

Dosyalar

Koleksiyon

WOS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu